Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

0 avis

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

Archive ouverte

Edité par CCSD ; Elsevier Masson -

International audience. As conflicting results have been observed by some authors in liver recipients, the aim of the study was to evaluate lamivudine therapy in 3 groups of patients with chronic hepatitis B: non-transplanted patients, liver and kidney recipients.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.. Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.: HBV genotypes in Southwestern France

Archive ouverte | Trimoulet, Pascale | CCSD

International audience. OBJECTIVE: To determine the prevalence of HBV genotypes in Southwestern France and the association between HBV genotypes and patients characteristics.METHODS: 194 HBsAg-positive patients (med...

Psychosocial factors associated with perceived disease severity in patients with chronic hepatitis C : relationship with information sources and attentional coping styles

Archive ouverte | Constant, Aymery | CCSD

International audience

UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.

Archive ouverte | Garrigue, Isabelle | CCSD

International audience. BACKGROUND: Human cytomegalovirus (HCMV) is the most common opportunistic pathogen infecting immunocompromised patients after transplantation. Although its immunomodulatory capacities and gen...

Chargement des enrichissements...

Syracuse